Pharma2026-10-19 10:00 UTC
Anti-Obesity Treatments Weigh Too Heavily on Pockets, Ozempic May Offer a Solution
Researchers explore the potential of repurposing the diabetes medication Ozempic to combat obesity
Italian researchers are investigating the possibility of repurposing the diabetes medication Ozempic to treat obesity. The medication, which is a digital twin of a hormone that regulates blood sugar, has shown promising results in clinical trials. By simulating the effects of Ozempic on a digital twin of the human body, scientists can test its efficacy and safety without the need for human trials.
Source: il Giornale — read the original article
This article is an independent rewrite and summary, not a reproduction of the original.
← back to feed
This article is an independent rewrite and summary, not a reproduction of the original.